Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Hiddo J.L. Heerspink

ResearcherPublications, citations & collaboration network

Hiddo J.L. Heerspink is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,082 works, 66,421 citations, an h-index of 121 and an i10-index of 510.

1,082
Works
66,421
Citations
121
h-index
510
i10-index

How has Hiddo J.L. Heerspink's publication output changed over time?

ScholarIQpublication output · 2012–2022

Output grew100% over the shown period — from 1 works in 2012 to 2 in 2022.

1
2
2
2
2
1
2
2012201320162017201920202022

What are the most-cited papers on Hiddo J.L. Heerspink?

ScholarIQmost cited works
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal, Séverine Bompoint, Hiddo J.L. Heerspink, David M. Charytan, Robert Edwards, Rajiv Agarwal, George L. Bakris, Scott Bull, Christopher P. Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M. Brenner, Kenneth W. Mahaffey
New England Journal of Medicine. 20196,091 CitationsOPEN ACCESS
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter, Glenn M. Chertow, Tom Greene, Fan Fan Hou, Johannes F.E. Mann, John J.V. McMurray, Magnus Lindberg, Peter Rossing, C. David Sjöström, Roberto D. Toto, Anna-Maria Langkilde, David C. Wheeler
New England Journal of Medicine. 20205,353 CitationsOPEN ACCESS
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Ron T. Gansevoort, Ricardo Correa‐Rotter, Brenda R Hemmelgarn, Tazeen H. Jafar, Hiddo J.L. Heerspink, Johannes F.E. Mann, Kunihiro Matsushita, Chi Pang Wen
The Lancet. 20132,225 CitationsOPEN ACCESS
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
Caroline S. Fox, Kunihiro Matsushita, Mark Woodward, Henk J.G. Bilo, John Chalmers, Hiddo J.L. Heerspink, Brian J. Lee, Robert M. Perkins, Peter Rossing, Toshimi Sairenchi, Marcello Tonelli, Joseph A. Vassalotti, Kazumasa Yamagishi, Josef Coresh, Paul E. de Jong, Chi-Pang Wen, Robert G. Nelson
The Lancet. 20121,397 CitationsOPEN ACCESS
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
Hiddo J.L. Heerspink, Bruce A. Perkins, David Fitchett, Mansoor Husain, David Z.I. Cherney
Circulation. 20161,367 Citations

Related on ScholarIQ

New South Wales Department of Health
Institution
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Paper
Dapagliflozin in Patients with Chronic Kidney Disease
Paper
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Paper
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
Paper
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
Paper
470M+ articles · free account